Clinical significance of serum bilirubin and uric acid levels in patients with coronary heart disease
Ling Wen-hui
Abstract
Ling Wen-hui
Abstract
Objective To investigate the clinical significance of serum bilirubin and uric acid levels in patients with coronary heart disease (CHD). Methods Thirty-five CHD patients who were admitted to our hospital were selected as an observation group; meanwhile, 35 healthy persons who received physical examination were selected as a control group. Both groups underwent blood routine test and were then compared in terms of serum uric acid level, serum total bilirubin level, and serum direct bilirubin level. Results Compared with the control group, the observation group showed a significantly higher serum uric acid level (P0.05) but a significantly lower serum total bilirubin level (P0.05). Compared with those with only one artery affected, the CHD patients with more than one artery affected had a significantly higher serum uric acid level (P0.05) but a significantly lower serum bilirubin level(P0.05). There was no significant difference in serum direct bilirubin level between the two groups (P0.05). Conclusion There are significant differences in serum total bilirubin level and serum uric acid level between CHD patients and healthy people, and the two indices are indicative of the progression of CHD. Thus, the two indices can be measured clinically in the examination of CHD patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the clinical significance of serum bilirubin and uric acid levels in patients with coronary heart disease (CHD). Methods Thirty-five CHD patients who were admitted to our hospital were selected as an observation group; meanwhile, 35 healthy persons who received physical examination were selected as a control group. Both groups underwent blood routine test and were then compared in terms of serum uric acid level, serum total bilirubin level, and serum direct bilirubin level. Results Compared with the control group, the observation group showed a significantly higher serum uric acid level (P0.05) but a significantly lower serum total bilirubin level (P0.05). Compared with those with only one artery affected, the CHD patients with more than one artery affected had a significantly higher serum uric acid level (P0.05) but a significantly lower serum bilirubin level(P0.05). There was no significant difference in serum direct bilirubin level between the two groups (P0.05). Conclusion There are significant differences in serum total bilirubin level and serum uric acid level between CHD patients and healthy people, and the two indices are indicative of the progression of CHD. Thus, the two indices can be measured clinically in the examination of CHD patients.
Key concepts: Bilirubin, Medicine, Uric acid, Internal medicine, Clinical significance, Gastroenterology, Serum bilirubin, Coronary artery disease